9.ALPHA.-FLUORO-11.BETA.,16.ALPHA.,17.ALPHA.,21-TETRAHYDROXY-5.BETA.-PREGNA-20-ONE-(3,2-C)-2'-PHENYLPYRAZOLE 16,17-ACETONIDE
UNII UCV1HVO0QS
Substance Identification & Data
This profile provides standardized clinical and technical data for 9.alpha.-fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxy-5.beta.-pregna-20-one-(3,2-c)-2'-phenylpyrazole 16,17-acetonide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UCV1HVO0QS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23816-54-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H39FN2O5 WPIUDZQIMYNBFN-UZGHATLQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9.alpha.-fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxy-5.beta.-pregna-20-one-(3,2-c)-2'-phenylpyrazole 16,17-acetonide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.